ITGB2 gene polymorphism and its relation to platelet phase of hemostasis activity in patients with coronary artery disease combined with type 2 diabetes

Abstract

One of the urgent problems of modern health care is the elucidation of the molecular-genetic basis of the development of cardiovascular diseases. One of the effective approach to studying the role of genetic mechanisms of pathogenesis is associated with the selection of genes that have the greatest contribution to the regulation of primary hemostasis, ensuring the adequacy of the platelet response. The GP IIb/IIIa receptor is the major platelet receptor whose molecular defects can lead to platelet hyperaggregation. The ITGB3 gene (GPIIIa) encodes a protein component of the platelet fibrinogen receptor, which provides the interaction of platelets with blood plasma fibrinogen, resulting in platelet aggregation and thrombus formation. The main goal of the study is to assess platelet aggregation activity in patients with various forms of coronary artery disease in combination with type 2 diabetes and different polymorphism of ITGB3 gene.